Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab (Journal of Neuro-Oncology, (2019), 145, 3, (461-466), 10.1007/s11060-019-03279-9)

Fayez Estephan, Xiaobu Ye, Omar Dzaye, Nina Wagner-Johnston, Lode Swinnen, Douglas E. Gladstone, Rich Ambinder, David Olayinka Kamson, Sebastian Lambrecht, Stuart A. Grossman, Doris D.M. Lin, Matthias Holdhoff

Research output: Contribution to journalComment/debatepeer-review

Abstract

The following discrepancies and errors were found in the original publication.

Original languageEnglish (US)
Pages (from-to)467
Number of pages1
JournalJournal of neuro-oncology
Volume145
Issue number3
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab (Journal of Neuro-Oncology, (2019), 145, 3, (461-466), 10.1007/s11060-019-03279-9)'. Together they form a unique fingerprint.

Cite this